These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16638584)

  • 1. Nuchal translucency and first-trimester screening.
    Harry WG; Reed KL
    J Soc Gynecol Investig; 2006 Apr; 13(3):153-4. PubMed ID: 16638584
    [No Abstract]   [Full Text] [Related]  

  • 2. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
    Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The prenatal detection of trisomy 13, 18, and 21: comparison of the advanced first trimester screening (AFS) with the first trimester screening according to Nicolaides].
    Hörmansdörfer C; Schmidt P; Hillemanns P; Scharf A
    Z Geburtshilfe Neonatol; 2007 Dec; 211(6):243-9. PubMed ID: 18176905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of serum markers in first-trimester down syndrome screening.
    Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
    Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening?
    Comstock CH; Malone FD; Ball RH; Nyberg DA; Saade GR; Berkowitz RL; Ferreira J; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Bianchi DW; D'Alton ME;
    Am J Obstet Gynecol; 2006 Sep; 195(3):843-7. PubMed ID: 16949423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
    Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First trimester Down's syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency.
    Bestwick JP; Huttly WJ; Wald NJ
    J Med Screen; 2008; 15(4):204-6. PubMed ID: 19106261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone.
    Sepulveda W; Wong AE; Dezerega V
    Obstet Gynecol; 2007 May; 109(5):1040-5. PubMed ID: 17470580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does vaginal bleeding influence first-trimester markers for Down syndrome?
    Heinig J; Steinhard J; Schmitz R; Nofer JR; Witteler R; Mosel A; Ahrens A; Kiesel L; Klockenbusch W
    Prenat Diagn; 2007 Apr; 27(4):312-6. PubMed ID: 17286311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Education and quality review for nuchal translucency ultrasound.
    D'Alton ME; Cleary-Goldman J
    Semin Perinatol; 2005 Dec; 29(6):380-5. PubMed ID: 16533651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuchal translucency in pregnancies conceived after assisted reproduction technology.
    Hui PW; Lee CP; Tang MH; Ho PC
    Curr Opin Obstet Gynecol; 2006 Jun; 18(3):319-24. PubMed ID: 16735833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness model for first-trimester versus second-trimester ultrasound screening for Down syndrome.
    Kott B; Dubinsky TJ
    J Am Coll Radiol; 2004 Jun; 1(6):415-21. PubMed ID: 17411619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quality of nuchal transluccency measurements: an exploratory study into their performance and evaluation].
    van den Berg M; Kleinveld JH; Sander MJ; van Vugt JM; Timmermans DR
    Ned Tijdschr Geneeskd; 2005 Jul; 149(30):1691-6. PubMed ID: 16104116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which contingent sequential screening protocol?
    Larsen SO; Christiansen M; Norgaard-Pedersen B
    Prenat Diagn; 2005 Dec; 25(12):1168-9; author reply 1169-70. PubMed ID: 16317663
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of first and second trimester aneuploidy risk assessment.
    Reddy UM; Wapner RJ
    Clin Obstet Gynecol; 2007 Jun; 50(2):442-53. PubMed ID: 17513930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prenatal screening and diagnostics after infertility treatment].
    Gjerris AC; Loft A; Pinborg AB; Christiansen M; Tabor A
    Ugeskr Laeger; 2007 Jan; 169(5):414-9. PubMed ID: 17280635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on antenatal screening for Down's syndrome and specific implications for assisted reproduction pregnancies.
    Weisz B; Rodeck CH
    Hum Reprod Update; 2006; 12(5):513-8. PubMed ID: 16672245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuchal translucency measurements for first-trimester screening: the 'price' of inaccuracy.
    Evans MI; Van Decruyes H; Nicolaides KH
    Fetal Diagn Ther; 2007; 22(6):401-4. PubMed ID: 17652924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.